Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Eur J Med Chem ; 138: 1066-1075, 2017 Sep 29.
Article in English | MEDLINE | ID: mdl-28759879

ABSTRACT

Amyloid-ß aggregation inhibitors are expected to be therapeutic or prophylactic agents for Alzheimer's disease. Rosmarinic acid, which is one of the main aggregation inhibitors derived from Lamiaceae, was employed as a lead compound and its 25 derivatives were synthesized. In this study, the structure-activity relations of rosmarinic acid derivatives for the amyloid-ß aggregation inhibitory effect (MSHTS assay), antioxidant properties, and xanthine oxidase inhibition were evaluated. Among the tested compounds, compounds 16d and 19 were found to the most potent amyloid aggregation inhibitors. The SAR revealed that the necessity of the presence of the phenolic hydroxyl on one side of the molecule as well as the lipophilicity of the entire molecule. The importance of these structural properties was also supported by docking simulations.


Subject(s)
Amyloid beta-Peptides/antagonists & inhibitors , Antioxidants/pharmacology , Cinnamates/pharmacology , Depsides/pharmacology , Amyloid beta-Peptides/metabolism , Antioxidants/chemical synthesis , Antioxidants/chemistry , Cinnamates/chemical synthesis , Cinnamates/chemistry , Depsides/chemical synthesis , Depsides/chemistry , Dose-Response Relationship, Drug , Humans , Molecular Dynamics Simulation , Molecular Structure , Protein Aggregates/drug effects , Structure-Activity Relationship , Rosmarinic Acid
2.
J Biosci Bioeng ; 120(1): 45-50, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25534595

ABSTRACT

Inhibitors of amyloid ß (Aß) aggregation have the potential to serve as lead compounds for anti-Alzheimer's disease (AD) agents because Aß aggregation is a key step in AD pathogenesis. Recently, we developed a novel microliter-scale high-throughput screening (MSHTS) system for Aß aggregation inhibitors that applied fluorescence microscopic analysis with quantum dot nanoprobes, and attempted to comprehensively screen the inhibitors from spices using this system (Ishigaki et al., PLoS One, 8, e72992, 2013). In this study, we tried to evaluate the inhibitory activities of 11 seaweed extracts on Aß aggregation using the MSHTS system. The half-maximal effective concentration (EC50) of the ethanolic extracts from all seaweeds exceeded 4.9 mg/ml, indicating that the extracts inhibit Aß aggregation although this activity was significantly lower than that displayed by members of the Lamiaceae, a family of herbal spices that showed highest activity among 52 spices tested in our 2013 study. On the other hand, the EC50 of boiling water extracts was 0.013-0.42 mg/ml which was comparable with the EC50 of the extracts from the Lamiaceae family. These results suggest that the extraction efficiency of the inhibitors by boiling water extraction was higher than that by ethanolic extraction. Moreover, analysis of fluorescence micrographs, which were obtained from the MSHTS system, revealed that the morphology of the Aß aggregates coincubated with boiling water extracts differed from control aggregates, suggesting that the MSHTS system is also useful for screening substances that affect the morphology of aggregates.


Subject(s)
Amyloid beta-Peptides/metabolism , Drug Evaluation, Preclinical/methods , High-Throughput Screening Assays/methods , Protein Aggregation, Pathological , Quantum Dots , Seaweed/chemistry , Tissue Extracts/pharmacology , Alzheimer Disease/drug therapy , Amyloid beta-Peptides/chemistry , Molecular Probes , Protein Aggregation, Pathological/drug therapy , Tissue Extracts/chemistry , Tissue Extracts/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL